Company: LIMN
Filing Date: 2025-05-06
Form Type: 8-K
Source: 0001104659-25-045127
Chunk: 5

Company: Liminatus Pharma, Inc.
Filing Date: 2025-05-06
Form: 8-K
Item: Item 5.06
Chunk 5
---
Item 5.06. Change in Shell Company Status.

As a result of the Business
Combination, Iris ceased being a shell company. Reference is made to the disclosure in the Proxy Statement/Prospectus in the section
titled “ The Business Combination Proposal” beginning on page 103 of the Proxy Statement/Prospectus, and such disclosure
is incorporated herein by reference. Further, the information contained in Item 2.01 of this Report is incorporated by reference into
this Item 5.06.

Item 7.01 Regulation FD Disclosure.